1.Hypertension. To use this drug solely or combined with other antihypertensive drugs. 2. Chronic stable angina and variant angina. To use this drug solely or combined with other anti-angina drugs.
For the treatment of mild and moderate acute ischemic stroke.
To alleviate the neurologic impairment for the patients of acute ischemic stroke.
To treat philadelphia chromosome-positive chronic myelogenous leukemia (Ph+CML) in chronic phase, acceleration phase or blastic phase. To treat adult patients with unresectable and/or metastatic malignant gastrointestinal stromal tumor (GIST). To treat recurrent refractory philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) in adults.
For the treatment of metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy。 Prior chemotherapy should include an anthracyclines unless clinically contraindicated。
For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP); for the treatment of adult relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)。
This medicine can be used as a first-line systemic chemotherapy drug or as a second-line chemotherapy drug for patients with progressive AIDS-KS or for patients who cannot tolerate the combination of the following two or more chemotherapy drugs: vincristine, bleomycin and doxorubicin (or other anthracyclines)。 The guidelines recommend treatment for ovarian cancer, lymphoma, multiple myeloma, breast cancer, uterine tumor, bone and soft tissue sarcoma。
For the treatment of mild and moderate vascular dementia, Alzheimer's disease, and the memory and intellectual disabilities caused by brain trauma and etc。。
For the treatment of mild and moderate vascular dementia, Alzheimer's disease, and the memory and intellectual disabilities caused by brain trauma and etc..